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Edited by Robert BaroukiAbstract Phosphatidic acid (PA) is implicated in pathophysio-
logical processes associated with cellular signaling events and
inﬂammation, which include the expressional regulation of
numerous genes. Here, we show that PA stimulation increases
matrix metalloproteinase-9 (MMP-9) expression in macro-
phages through tumor necrosis factor (TNF)-a signaling. We
performed antibody array analysis on proteins from macro-
phages stimulated with PA. PA was found to induce the produc-
tion of TNF-a, but not of TNF receptor (TNFR)1 and TNFR2 in
a time-dependent manner and stimulated signiﬁcant, though
delayed, MMP-9 expression. PA induced the phosphorylations
of both ERK1/2 and p38, but not of c-jun amino-terminal kinase.
Moreover, only ERK1/2 inhibition by U0126 suppressed PA-
induced TNF-a production and MMP-9 expression. Neutraliz-
ing TNF-a, TNFR1 or TNFR2 antibodies signiﬁcantly
suppressed PA-induced MMP-9 expression, suggesting that the
production of TNF-a in response to PA preceded the expression
of MMP-9. Moreover, lipopolysaccharide-induced PA also led
to TNF-a release and resulted in MMP-9 expression. Taken
together, these observations suggest that PA may play a role
in MMP-9 regulation through ERKs/TNF-a/TNFRs-dependent
signaling pathway.
 2007 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Macrophages play a central role in inﬂammatory responses.
These include the elimination of foreign stimuli, the initiation
of adaptive immune response, and regulation of the healing
process. This various activities require macrophages migrationAbbreviations: PA, phosphatidic acid; lysoPA, lysophosphatidic acid;
DAG, diacylglycerol; PLD, phospholipase D; mTOR, mammalian
target of rapamycin; IL, interleukin; ERK, extracellular signal-regu-
lated kinase; ECM, extracellular matrix; MMP, matrix metallopro-
teinase; TNF, tumor necrosis factor; MAPK, mitogen activated
protein kinase; C8-PA, 1,2-dioctanoyl-glycero-3-phosphate; TNFR,
TNF receptor; JNK, c-jun amino-terminal kinase; LPS, lipopolysac-
charide
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doi:10.1016/j.febslet.2007.01.048to other tissues and their fast adaptation to changing environ-
ments. To migrate across the extracellular matrix (ECM),
macrophages secrete several proteases, including matrix
metalloproteinases (MMPs). Macrophages are thought to play
an important role in this balance between inﬂammatory
responses and healthy process due to their ability to produce en-
zymes capable of degrading the ECM.MMPs are important en-
zymes to breakdown ECM components like gelatin and
collagen. TheMMPs consist of gelatinases, collagenases, strom-
elysins, and membrane type MMPs. Among these, MMP-2 and
MMP-9 are believed to be primarily responsible for the degrada-
tion of laminin and type IV collagen, the latter is a major com-
ponent of basement membranes [1]. MMP-2 is expressed
constitutively in many cell types, whereas MMP-9 is mostly in-
duced by proinﬂammatory stimuli, such as, tumor necrosis fac-
tor (TNF)-a, endotoxins, and interleukin (IL)-1, probably
through the activation of its transcription factor. In particular,
the macrophage expression of active MMP-9 induces acute
inﬂammatory responses like plaque disruption [2]. Additional
data from human genetic studies suggest that MMP-9 is the
strongest candidate for the induction ofmacrophage functional-
ities associated with inﬂammatory responses [1].
Phosphatidic acid (PA) is an important metabolite, and is
involved in phospholipid biosynthesis and membrane remodel-
ing. However, it is the regulatory function of PA that has
attracted attention in recent years. PA has emerged as a new
class of lipid mediator, like lysophosphatidic acid (lysoPA)
and sphingosine-1-phosphate [3]. The synthesis and turnover
of cellular PA can be regulated by several metabolic pathways,
such as, lysoPA acyl transferase, diacylglycerol (DAG) kinase
and phospholipase D (PLD) [3]. The generation of PA by the
PLD pathway is central to several physiological functions
including vesicular traﬃcking, secretion, phagocytosis, and
barrier alterations [4]. However, some data show that PA itself
plays a crucial role in the regulation of several important bio-
logical events. For instance, PA has been implicated in the reg-
ulation of cell growth [5,6] and protein phosphorylation [7,8],
and in the release of cytokines [9]. PA stimulates the mamma-
lian target of rapamycin (mTOR) signaling toward ribosomal
S6 kinase 1, and the eukaryotic translation initiation factor
4E binding protein 1 [5]. Hornberger et al. [10] suggested that
PA may directly interact with mTOR and modulate mechani-
cal load-induced growth of skeletal muscle.
PA has been described its function in relation to inﬂamma-
tion and cytokine release. We have previously shown that PAblished by Elsevier B.V. All rights reserved.
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murine macrophages [9]. Other groups have shown that PA
induce IL-8 secretion, and this secretion is regulated by extra-
cellular signal-regulated kinase (ERK)1/2 phosphorylation
[11]. The production of cytokines in inﬂammatory cells re-
quires activation gene transcription. These events are initiated
and regulated by a various intracellular kinases, which in turn
drive membrane signals to nuclear factors such as NF-jB [12].
Among signaling kinases, ERK1/2 play a prominent role in the
regulation of cytokines. For example, ERK1/2 is involved
in the pathways leading to cytokine production in murine
macrophages stimulated with lipopolysaccharide (LPS) [13].
In addition, other evidence has indicated that PA mediate
translocation of Raf-1 from the cytosol to the plasma mem-
brane [14]. Membrane-bound Ras then activates the PA-teth-
ered Raf-1 that initiates the ERK1/2 signaling cascades [15].
However, the involvement of these kinases in the production
of TNF-a by PA has not been deﬁned yet.
We interested in the possibility that PA may contribute to
TNF-a-mediated MMP-9 expression. In this study, we exam-
ined the signaling pathways that regulate PA-induced TNF-
a release from Raw264.7 murine macrophages and found that
TNF-a release is required forMMP-9 expression. Furthermore,
we found that ERK1/2 is critical for the regulation of TNF-
a-mediated MMP-9 expression in response to PA stimulation.2. Materials and methods
2.1. Reagents and cells
Cell culture reagents, including FBS, were purchased from Life
Technologies (Grand Island, NY), C8-PA, C8-DAG and NBD-PAFig. 1. PA induces TNF-a production by Raw264.7 macrophages. (A) Macro
PA for 6 or 24 h. Conditioned media were then assayed for various cytokin
various concentrations of PA for 1 h at 37 C or (C) 100 lM PA for speciﬁed
treated with the various phospholipids for 1 h and then measured TNF-a rewere from Avanti (Alabaster, AL), mouse cytokine antibody arrays
from RayBiotech (Norcross, GA), TNF-a ELISA kit, and MMP-9
and TNF receptor (TNFR)1 antibodies from R&D Systems (Minneap-
olis, MN). TNFR2 antibody was purchased from Santa-Cruz Biotech-
nology (Santa-Cruz, CA), and ERK1/2, phospho-ERK1/2, p38, and
phospho-p38 antibodies were from Cell Signaling Inc. (Beverley,
MA). U0126 and mitogen activated protein kinase (MAPK) inhibitors
were purchased from Calbiochem (San Diego, CA), and murine
macrophages Raw264.7 cells (ATCC, CCL-2278) were grown in RPMI
1640 supplemented with 10% FBS, 2 mM L-glutamine, and 1%
antibiotics. Culture dishes were maintained in humidiﬁed 5% CO2 at
37 C.
2.2. Gelatin zymography
MMP activity was determined by gelatinase zymography using 0.1%
gelatin as a substrate in 10% SDS–polyacrylamide gel. After electro-
phoresis, gels were washed for 30 min with 2.5% Triton X-100 in water
and then incubated overnight at 37 C in 0.2% Brij 35, 5 mM CaCl2,
1 mMNaCl, and 50 mM Tris (pH 7.4), in a closed container. Gels were
then stained for 1 h with 0.2% Brilliant Blue in 10% acetic acid and
50% ethanol and destained for 30 min using an aqueous mixture of
10% acetic acid, and 30% methanol. Areas of protease activity
appeared as clear bands.
2.3. Cytokine antibody array
After incubation for the indicated times at 37 C, conditioned media
were harvested from cells treated with PA, centrifuged at 700 · g for
10 min to remove cell debris, and stored at 80 C for cytokine anal-
ysis. Conditioned media were probed for cytokine proﬁles using the
RayBio mouse cytokine antibody array 1.1 kit according to the man-
ufacturer’s instructions. Brieﬂy, membranes were blocked with a
blocking buﬀer, and then 2 ml of medium from each culture of treated
cells was added and incubated at 4 C overnight. Membranes were
washed and primary biotin-conjugated antibody was added and
incubated at room temperature for 2 h. The membranes were then
incubated with 2 ml of horseradish peroxidase-conjugated streptavidin
at room temperature for 30 min. Cytokine presence was detected by
enhanced ECL system.phages were incubated in medium alone or medium containing 100 lM
es and receptors using an antibody array. Cells were treated with (B)
times at 37 C. TNF-a release was measured by ELISA. (D) Cells were
lease from conditioned medium.
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Cells were plated in wells and treated with PA in the presence or
absence of inhibitor. They were then washed with cold-PBS, and
pelleted at 700 · g. Cell pellets were re-suspended in lysis buﬀer
(50 mM Tris–HCl, pH 8.0, 5 mM EDTA, 150 mM NaCl, 0.5% Non-
idet P-40, 1 mM PMSF, and protease inhibitor cocktail), cleared by
centrifugation, and supernatants were saved as cell lysates. Proteins
were separated by 10% reducing SDS–PAGE and immunoblotted in
20% methanol, 25 mM Tris, and 192 mM glycine onto nitrocellulose
membranes. Membranes were then blocked with 5% non-fat dry milk
in TTBS (25 mM Tris–HCl, 150 mM NaCl, and 0.2% Tween-20) and
incubated with the antibody for overnight. Subsequently, membranes
were washed and incubated for 1 h with secondary antibody conju-
gated to HRP. Finally, membranes were washed and developed using
an enhanced ECL system by LAS-3000 analyzer (Fujiﬁlm, Japan). For
MAPKs phosphorylation, cells were treated with PA and Western
blotting was performed as described above, membranes so obtained
were probed with antibody against active (phosphorylated) MAPKs.
Blots were stripped and reproved with antibody recognizing total form
of each MAPK to demonstrate equal loading.
2.5. Detection of soluble TNF-a
Raw264.7 cells were incubated for 1 h in PA alone or containing var-
ious inhibitors. At designated times conditioned media were harvested
and assayed for TNF-a in triplicate wells by ELISA as described by the
manufacturer. The data shown represent at least three independent
experiments.
2.6. Real-time RT-PCR
Total RNA was extracted from cells using Tri reagent (Invitrogen,
Carlsbad, CA). One microgram of total RNA was used as a template
to make ﬁrst strand cDNA by oligo-dT priming using the Promega
reverse transcriptase system. Real-time RT-PCR was performed using
LightCycler 1.5 (Roche Diagnostics, Almere, Netherlands) and SYBR-
Green I as the ﬂorescent dye to enable the real-time detection of PCR
products, according to the manufacturer’s instructions. The synthetic
gene-speciﬁc primer sets used in PCR were: (i) TNF-a forward primer,
5 0-TTC TGT CTA CTG AAC TTC GGG GTG ATC GGT CC-3 0,
and reverse primer, 5 0-GTA TGA GAT AGC AAA TCG GCT
GAC GGT GTG GG-3 0, which ampliﬁed 354-bp of mouse TNF-a
cDNA; (ii) MMP-9 forward primer, 5 0-CCT ACT CTG CCT GCA
CCA CTA AA-3 0, and reverse primer, 5 0-CTG CTT GCC CAG
GAA GAC GAA-30, which ampliﬁed 179-bp of mouse MMP-9
cDNA; (iii) b-actin forward primer, 5 0-AGA GGG AAA TCG TGC
GTG AC-3 0, and reverse primer, 5 0-CAA TAG TGA TGA CCT
GGC CGT-3 0, which ampliﬁed 137-bp of mouse b-actin cDNA.
Cycling conditions were 94 C for 3 min, followed by 45 cycles of
95 C for 5 s, 62 C for 5 s, and 72 C for 12 s. For quantiﬁcation,
target genes were normalized versus b-actin.Fig. 2. PA stimulates MMP-9 expression by macrophages. (A)
Macrophages were plated on 6-well plates in medium containing
10% FBS. Following overnight serum starvation, cells were treated
with PA at the indicated concentrations. The conditioned media were
collected at 24 h and analyzed for MMP-9 expression and activity by
Western blotting and zymography. (B) Cells were cultured with PA
(100 lM) for the indicated times and conditioned media were collected
and analyzed for MMP-9 expression and activity by Western blotting
and zymography. The results shown are representative of three
separate experiments. (C) Cells were cultured with PA for the indicated
times and total RNA was isolated from cells and then subjected to real-
time RT-PCR. The graph represents fold changes of TNF-a and
MMP-9 mRNA levels normalized by b-actin mRNA after cells had
been treated with PA.3. Results
3.1. Eﬀect of exogenous PA stimulation on TNF-a release in
macrophages
In order to increase cellular levels of PA, we added a water-
soluble synthetic PA (C8-PA) to cell cultures. To examine the
mechanisms involving cytokines in PA-induced signaling, we
ﬁrst used cytokine antibody arrays, and then studied TNF-a
production in macrophages. In unstimulated cells, very low
levels of TNF-a were detected. However, PA induced a signif-
icant increase in TNF-a release by 6 h, which increased more
so at 24 h. Meanwhile the basal level of both soluble TNFR1
and TNFR2 was quite high, but the expression of neither
TNFR1 nor TNFR2 was aﬀected by PA stimulation
(Fig. 1A). There are no changes of other spots between unstim-
ulated and PA-stimulated cells. To conﬁrm that TNF-a de-
tected after PA stimulation represented a speciﬁc increase
from antibody array, we performed TNF-a production assay
using ELISA. A signiﬁcant increase in TNF-a release abovethe control level was observed in cells cultured for 1 h with
PA concentrations ranging from 20 to 200 lM (Fig. 1B). Cells
treated with 100 lM PA for 1 h also showed signiﬁcantly
increased TNF-a levels compared with unstimulated control
cells (Fig. 1C). Additions of PA are complicated by the fact
that it may be further metabolized to DAG or lyso-PA in
the cells. Because the lyso derivative of C8-PA is not commer-
cially available, we used lysoC6-PA. Addition of lysoC6-PA or
C8-DAG did not cause release of TNF-a in cells (Fig. 1D).
These results imply that PA acts directly on cellular targets,
independently of DAG or lyso derivatives.
3.2. PA induced the expression of MMP-9 in macrophages
To determine whether PA induces the expression of MMP-9
in macrophages, cells were treated with PA, and levels of
MMP-9 protein in culture medium were determined. After
24 h of treatment, PA enhanced MMP-9 protein expression
in a concentration-dependent manner. To determine whether
MMP-9 protein released in response to PA was biologically
active, we assessed the gelatinolytic activities of culture super-
natants. As shown in Fig. 2A, low gelatinolytic activity was
detected in control supernatant, whereas the supernatants of
Fig. 4. ERK1/2 activation is required for TNF-a and MMP-9
expression. (A) Cells were pretreated with 1 lM U0126, 10 lM
SB203580, or 5 lM SP600125 for 1 h before being treated with PA
(100 lM) for 1 h. Conditioned media were collected and TNF-a release
was measured by ELISA. (B) Cells were pretreated with speciﬁc
inhibitors for 1 h before adding 100 lM PA for 30 min (for ERK1/2
phosphorylation) or 24 h (for MMP-9). Whole cell lysates were
Western blotted for phospho-ERK1/2, as indicated. Equal lane
loading was conﬁrmed by for total ERK1/2. Conditioned media were
collected at 24 h and analyzed for MMP-9 expression and activity by
Western blotting and zymography.
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related with MMP-9 protein levels. Cells treated with PA for
the indicated times also showed increased MMP-9 levels and
activities compared with unstimulated cells (Fig. 2B). Addition
of lysoC6-PA or C8-DAG did not change expression of MMP-
9 in cells (data not shown). We next investigated the eﬀects of
PA on TNF-a and MMP-9 mRNA levels in macrophages.
Cells were treated with PA for diﬀerent times between
30 min and 9 h. The mRNAs of TNF-a and MMP-9 were also
found to be increased by PA stimulation, although their kinet-
ics diﬀered. In particular, PA induced the expression of TNF-a
mRNA earlier than MMP-9 mRNA (Fig. 2C).
3.3. PA-induced TNF-a and MMP-9 expressions via ERK1/2
pathway
Because PA has been implicated in the activation of the
Raf-1/MAPK pathway [14], we examined the eﬀect of PA on
MAPKs activation, using Western blot analysis with anti-
phospho-speciﬁc antibodies against the three MAPKs. After
exposure to PA for various periods of time, macrophages were
harvested and ERK1/2, p38 and c-jun amino-terminal kinase
(JNK) phosphorylations were measured. As shown in
Fig. 3A, PA signiﬁcantly triggered the phosphorylation of
both ERK1/2 and p38 MAPK, and these peaked after
30 min of stimulation and sustained up to 60 min. Both
MAPKs phosphorylations were also increased by PA stimula-
tion in a dose-dependent manner (Fig. 3B). However, JNK
phosphorylation was not increased by PA stimulation (data
not shown). To determine whether activation of MAPKs plays
a role in the regulation of TNF-a and MMP-9, cells were pre-
treated with MAPK selective inhibitors for 1 h and then trea-
ted with PA for the indicated times. The viability of the cells
was no eﬀect after treatment of inhibitors. As shown in
Fig. 4, inhibition of ERK1/2 phosphorylation with U0126
reduced PA-induced TNF-a production and MMP-9 expres-
sion, and in agreement with these results, we found thatFig. 3. (A) PA stimulates ERKs and p38 phosphorylation in macrophages. Macrophages were treated with PA (100 lM) for the indicated times (A)
or with the indicated concentrations for 30 min (B). Whole cell lysates were Western blotted for phospho-MAPKs, as indicated. Equal lane loading
was conﬁrmed by detecting blots for total MAPKs. Relative amounts of phospho-ERK or phospho-p38 were determined using densitometry and
then plotted. The results shown are representative of two separate experiments.
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inhibition of p38 or JNK did not signiﬁcant aﬀect PA-induced
TNF-a release and MMP-9 expression. To conﬁrm whether
the activation of ERK1/2 plays a role in the regulation of
MMP-9 expression, we measured MMP-9 mRNA levels in
the presence of U0126. Analysis of mRNA demonstrated that
U0126 strongly inhibited TNF-a and MMP-9 mRNA (data
not shown). These results suggest that ERKs play critical roles
in the PA-induced TNF-a and MMP-9 expressions.
3.4. PA induces MMP-9 expression via secretion of TNF-a
The above results demonstrate that PA induces the expres-
sion of TNF-a mRNA earlier than MMP-9 mRNA. Experi-
ments were therefore undertaken to determine whether
MMP-9 exerts its eﬀects through TNF-a. In addition, because
TNF-a is a key modulator of MMP-9, we focused on the PA-
induced expression of TNF-a and its receptors. Stimulation
with PA induced a transient increase in the mRNA levels of
TNF-a. We conﬁrmed the expressional patterns of TNFR1
and TNFR2 by Western blotting, which did not change in
response to PA (data not shown). These ﬁndings conﬁrm the
antibody array data, and suggest that PA induces the expres-
sion of TNF-a, but not of TNFRs by macrophages. Next, to
examine whether the PA-induced MMP-9 expression by mac-
rophages is TNF-a-dependent, cells were pretreated with neu-
tralizing anti-TNF-a antibody. Consistent with the previous
results, MMP-9 was increased in the conditioned media of cells
after PA stimulation. However, cells treated with anti-TNF-a
antibody failed to express MMP-9 or TNF-a in response to
PA (Fig. 5A), indicating that PA-induced MMP-9 expression
by macrophages requires TNF-a signaling. In addition, anFig. 5. Extracellular or intracellular PA-induced MMP-9 expression was m
pretreated with neutralizing anti-TNF-a antibody (2 lg/ml) for 1 h before ad
TNF-a release and MMP-9 expression. (B) Cells were grown in 6-well plate
butanol for 6 h. Conditioned media were collected and analyzed for TNF-a
neutralizing anti-TNF-a antibody or anti-TNFR1/2 antibodies for 1 h befo
analyzed for MMP-9 expression.isotype-matched control antibody IgG had no eﬀect on
MMP-9 expression (data not shown). To conﬁrm the physio-
logical function of PA, we used LPS for the increase of intra-
cellular PA. Previously, we have reported that LPS stimulate
acute increase of PA formation by PLD activity and PLD2
is predominantly expressed in Raw264.7 cells [9]. To determine
whether intracellular PA formation is involved in the TNF-a
release and MMP-9 expression, we used 1-butanol which is
inhibitor of PLD activity. 1-Butanol signiﬁcantly blocked the
LPS-stimulated TNF-a release and MMP-9 expression while
tert-butanol did not aﬀect this LPS stimulatory eﬀect
(Fig. 5B), thus conﬁrming the speciﬁcity of involvement of
intracellular PA in the PLD-mediated eﬀect.
3.5. PA induces MMP-9 expression through TNFR1/2
TNF-a can bind and signal through TNFR1 and TNFR2,
and macrophages express both of these receptors [16]. We used
receptor-speciﬁc neutralizing antibodies to determine the role
of each receptor subtype with respect to the elicitation of
MMP-9 expression using Western blotting and zymography.
MMP-9 expression was reduced signiﬁcantly in cells treated
with neutralizing anti-TNFR1 antibody or anti-TNFR2 anti-
body. Moreover, both antibodies in combination had no great-
er eﬀect than anti-TNFR2 treatment alone (Fig. 5C). In
addition, an isotype-matched control antibody IgG had no
eﬀect on MMP-9 expression (data not shown). Similar results
were obtained by MMP-9 zymography. These ﬁndings suggest
that both TNFR1 and 2 are the important receptor involved in
PA-induced MMP-9 expression in mouse macrophages. Fur-
thermore, to conﬁrm whether the LPS-stimulated MMP-9
expression is also TNF-a- or TNFR-dependent, cells wereediated via a TNF-a and TNFRs signaling pathway. (A) Cells were
ding PA (100 lM). Conditioned media were collected and analyzed for
s and treated with 10 ng/ml LPS in the presence of 1-butanol or tert-
release and MMP-9 expression. (C and D) Cells were pretreated with
re adding PA or LPS. Conditioned media were collected at 6 h and
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antibody. As shown in Fig. 5D, MMP-9 expression by LPS
was reduced signiﬁcantly in cells treated with neutralizing
anti-TNF-a or anti-TNFR1/2 antibody.4. Discussion
In this study, we examined the PA function of TNF-a and
MMP-9 regulation in murine macrophages, which are may
be involved in macrophage extravasation from blood vessels
and migration in damaged tissue. Our previous study showed
that PA stimulates the release of inﬂammatory cytokines such
as TNF-a by Raw264.7 cells. Although the induction of
MMP-9 by PLD activation has been reported previously
[17,18], it elicitation of MMP-9 expression and the intracellular
signaling pathways are not well understood. In the present
study, we further examine that PA-induced ERK1/2 activation
regulates the expression of MMP-9 through the TNF-a and its
receptor signaling.
Inﬂammation includes the accumulation of inﬂammatory
cells and the increased degradation of ECM components. Mac-
rophages are the most important inﬂammatory eﬀector cells
and invariably accumulate at sites of inﬂammation [19]. More-
over, activated macrophages release cytotoxic molecules such
as cytokines that cause tissue damage and are associated with
the manifestations of various diseases, e.g., arthritis and sepsis.
When tissue is being degraded in this manner, increased ECM
turnover can result in the release of the degradation products of
ECM components. TNF-a is a powerful cytokine of inﬂamma-
tion and can be produced by a variety of cell types, including
macrophages and monocytes [12,16]. Although TNF-a has a
central role in the innate immune system for protection against
infections, when produced in excess, TNF-a may also orches-
trate chronic inﬂammatory responses that lead to severe tissue
damage. Thus, the regulation of inﬂammatory cell functions by
interactions with basement membrane components may pro-
vide important information concerning how inﬂammatory re-
sponses are resolved. Following our initial observation that
MMP-9 expression was upregulated in macrophages by PA,
we hypothesized that this increased MMP-9 expression may
have been triggered by an early event such as TNF-a release
from cells. Because TNF-a can induce MMP-9 expression via
the activation of speciﬁc cell signaling [20,21], we tested the
hypothesis that PA induces the macrophage production of
MMP-9 via TNF-a-dependent signaling. Our results show that
PA increased the release of TNF-a before the expression of
MMP-9 and TNFR1/2 is required for this MMP-9 expression.
Several studies have suggested that PA regulates speciﬁc ki-
nase cascades. For example, in vitro studies have demonstrated
that there are at least two-protein kinase activities, including
protein kinase C, regulated by PA [22,23]. The most character-
ized functional role of PA is the regulation of Raf-1/ERKs cas-
cades [15]. ERK1/2 has been shown to serve as important
regulators of inﬂammation. In addition, ERKs have been
found to regulate MMPs including MMP-9, and a number
of proinﬂammatory cytokines including TNF-a, IL-1b, and
IL-6 in many inﬂammatory diseases [20,24]. In the present
study, treatment of cells with PA caused a transient increase
in ERK1/2 phosphorylation. Notably, the inhibition of
ERK1/2 phosphorylation by U0126 dramatically reduced theexpressions of MMP-9 at the protein and mRNA levels. This
reduction in MMP-9 mRNA was not due to artifactual
RNA degradation during RNA preparation or the reverse
transcription reaction because the result was reproducible
and there was no concomitant decrease in b-actin mRNA lev-
els. These data suggest that the activity of ERK1/2 plays a role
in the regulation of MMP-9 expression in macrophages by PA.
Increasing cellular levels of PA (by adding exogenous C8-
PA) promotes TNF-a release, and TNFRs signaling was found
to be critically required for MMP-9 expression. One complica-
tion of studying the functions of PA is that there is obscure
how it enters cells. Our studies rely to a signiﬁcant extent on
adding short chain C8-PA to cells. Direct administration of
PA to examine its cellular eﬀects is potentially problems be-
cause PA may not be delivered to appropriate cellular loca-
tions. However, adding of ﬂuorescent PA (NBD-C6-PA) is
incorporated into cells very fast, which is observed under the
confocal microscopy (data not shown). The other complication
of PA studying is that they are convertible into lyso-PA or
DAG. It is unlikely that it acts by lyso-PA, because most as-
says were performed in serum except MMP-9 assay, which
contains biologically saturating amounts of lyso-PA, and ly-
soC6-PA was inactive in inducing TNF-a production. It is also
unlikely that C8-PA acts after hydrolysis to C8-DAG, because
there is no eﬀect of C8-DAG in the TNF-a release. Moreover,
the disposition of PA has always been an issue when PA is
added to intact cells because PA used extremely high concen-
tration about 100 lM. Although PA is present small amounts
in biological membranes, however PA concentration is esti-
mated to be 50–150 lM in plant [25,26]. This may also be rel-
evant in PA signaling because others have observed that high
concentrations of exogenous C8-PA (about 250 lM) serve as
a regulator of cell motility [27,28]. Moreover, PA is well-
known lipid product by PLD activation [3]. To evaluate the
signiﬁcance of intracellular PA, we used an established model
of LPS stimulation in Raw264.7 cells. Alcohols compete with
water as hydroxyl donors in the hydrolysis of phospholipids
by PLD, which results in the production of phosphatidylalco-
hol at the expense of PA. Treatment of macrophages with 1-
butanol, not tert-butanol, suppressed the LPS-stimulated
TNF-a release and MMP-9 expression. These results suggest
that the involvement of intracellular PA in the LPS-stimulated
TNF-a release and MMP-9 expression.
The biological activities of TNF-a are mediated by two
main, but functionally distinct, receptors, i.e., TNFR1 and
TNFR2. Although the binding of activated TNF-a to its
receptors can result in the activation of various events,
signaling triggered by TNFR1 and TNFR2 usually causes
the activation and induction of numerous genes involved in
inﬂammatory responses. TNFR1 is constitutively expressed
in most cell types, and the majority of inﬂammatory responses
classically attributed to TNF-a are mediated by TNFR1 [16].
Studies using TNFR knock-out mice revealed that TNFR1
plays a critical role in inﬂammatory response and tissue dam-
age [29]. However, some evidence indicate that TNFR2 signal-
ing also plays an important role in chronic inﬂammatory
conditions [30]. Our ﬁndings showed that the PA-induced
expression of MMP-9 by macrophages is mediated through
both TNFR1 and TNFR2. In addition, these ﬁndings impli-
cate that PA does not only aﬀect on the expression of both
TNFRs, there is no favorable receptor to execute TNF-a sig-
naling which results in MMP-9 expression either.
J.-G. Lee et al. / FEBS Letters 581 (2007) 787–793 793In conclusion, this study shows that ERK1/2 is essential for
the induction of TNF-a release and MMP-9 expression by PA.
Furthermore, based on the MMP-9 inhibitory eﬀects of spe-
ciﬁc TNF-a or TNFR neutralizing antibodies, we conclude
that TNF-a and TNFRs signaling is a major determinant of
PA-induced MMP-9 expression by macrophages. Our ﬁndings
provide new clues concerning the mechanism of inﬂammation
and on its regulation.
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